Author: Site Editor Publish Time: 08-28-2026 Origin: Site
Skin boosters have been used in aesthetic practice for years, and their role is now clearer: they are designed to support the skin’s own repair and regenerative processes.
However, the same product can produce different patient feedback from one clinic to another. The difference is not always in the product itself. Injection depth, dosage, technique, and treatment intervals can all affect the treatment experience and results.
Using PNPure™ as an example, let’s take a look at the key operating parameters and treatment plan design for skin booster injections.
Unlike traditional cross-linked Hyaluronic Acid (HA) fillers that physically hold space, or non-crosslinked HA boosters that primarily restore epidermal hydration, Polynucleotide (PN) boosters act as biologic wound-healing and repair stimulators.
Take PNPure™ as an example. When injected into the dermal layer, PN can support fibroblast activity and extracellular matrix remodeling. Clinical outcomes typically include improved skin density, elasticity, fine line reduction, and refined dermal texture.
The following parameters are practical references for PNPure™. Always follow the product’s approved instructions and adjust treatment according to the patient and treatment area.
Treatment Zone | Recommended Depth | Needle / Cannula Size | Injection Technique | Dose Per Point | Total Recommended Volume |
Mid & Lower Face (Cheeks) | 0.8 mm – 1.0 mm (Mid-Dermis) | 30G–32G $4\text{mm}$ Needle or 25G/27G Cannula | Micro-droplet (Mesotherapy) or Linear Threading | 0.02 – 0.03 mL | 2.0 mL – 4.0 mL |
Periorbital Area (Crow's Feet / Under Eye) | 0.5 mm – 0.8 mm (Superficial Dermis) | 32G–34G $4\text{mm}$ Ultra-fine Needle | Micro-papular technique (1.0 cm spacing) | 0.01 – 0.02 mL | 0.5 mL – 1.0 mL per eye |
Perioral & Smoker's Lines | 0.8 mm (Superficial Dermis) | 32G Needle | Micro-droplet or Cross-hatching | 0.01 – 0.02 mL | 0.5 mL – 1.0 mL |
Neck (Horizontal Lines & Laxity) | 0.8 mm – 1.0 mm (Intradermal) | 30G–32G Needle | Linear retrograde along lines or micro-papular grid | 0.02 mL | 2.0 mL |
Dorsum of Hands | 1.0 mm (Subdermal / Superficial Dermis) | 27G Cannula or 30G Needle | Fan technique via cannula or micro-droplet grid | 0.02 – 0.05 mL | 1.0 mL – 2.0 mL per hand |
A single session will initiate biological signaling, but tissue regeneration requires a structured treatment cycle.
A typical PNPure™ protocol is 2–3 sessions spaced 3–4 weeks apart. After the initial treatment course, maintenance treatment can be considered every 6–12 months based on the patient’s response and treatment goals.
Besides injection technique, it is also necessary to understand the ideal candidates and provide clear aftercare instructions.
PN skin boosters may be suitable for patients with fine lines, mild skin laxity, enlarged pores, rough texture, or dull-looking skin related to photoaging. They may also be considered for persistently dry skin, reduced moisture retention, or visible horizontal neck lines.
Patients with sensitive-looking skin and redness may also be considered when the treatment goal is to improve overall skin quality rather than add volume.
Patient selection should come before treatment. Review medical history, allergies, current medication, skin condition, and treatment expectations before proceeding.
Immediate (0–6 Hours): Keep injection sites clean and dry. Avoid touching or applying non-sterile products to open injection channels.
First 24 Hours: Refrain from applying makeup or washing the face with harsh cleansers.
First 48 Hours: Avoid strenuous physical exercise, saunas, steam rooms, and alcohol consumption to minimize localized edema and bruising.
First 7 Days: Apply broad-spectrum physical sunscreen daily and avoid direct high-UV exposure.
PN treatment does not produce its full effect immediately. Changes are usually gradual.
Timeframe | Expected Clinical Progression | Clinical Observation & Management |
Days 1–3 | Injection papules and transient edema | Mild papules/swelling at injection points are normal and resolve naturally within 24–72 hours. |
Week 1 | Initial hydration and inflammatory downtime | Skin barrier recovery begins; vascular flushing decreases. |
Weeks 2–4 | Collagen remodeling onset | Refined skin texture, smoother touch, and improved radiance become noticeable. |
Months 1–3 | Peak tissue regenerative effect | Enhanced dermal thickness, improved elasticity, and fine line softening. |
Months 4–6 | Treatment outcomes are stabilizing | Results may gradually decline but can remain above baseline |
Months 6–12 | Baseline maintenance phase | Re-evaluate skin condition to determine timing for maintenance administration. |
Temporary redness, swelling, and bruising are common injection-related reactions and generally resolve within several days. Small nodules can occur, particularly with overly superficial placement or excessive product at one point. Careful injection technique and dose control can help reduce this risk.
Optimal outcomes with polynucleotide skin boosters depend equally on high-purity product formulation and accurate clinical execution. By mastering injection depth, point distribution, and session spacing, aesthetic practitioners can deliver predictable, natural skin revitalization.
For Aesthetic Clinics & Medical Distributors:
Dermax provides premium-grade PN solutions, including PNPure™, backed by strict quality control standards and comprehensive clinical protocols.
Request Clinical Product Dossier & B2B Wholesale Pricing: Contact Our Aesthetic Specialist
content is empty!
